Skip to main content
XERS logo

XERS · Xeris Biopharma Holdings, Inc. · Executive Compensation

Track XERS — free
$11.13 +0.18 (+1.64%) At close · Oct 20
Market Cap
$2.05B
Shares
182.32M
Volume · Oct 20 2.9M Avg daily vol (3M) 2.29M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
John Shannon $5,042,584
Kevin McCulloch $2,270,973
Anh Nguyen $2,000,648
Beth P. Hecht $1,895,274
Steven M. Pieper $1,874,090
Fiscal 2024
Executive Total
Paul Edick $6,826,608
John Shannon $3,827,109
Beth P. Hecht $2,612,825
Kevin McCulloch $2,577,572
Steven M. Pieper $1,854,017
Ken Johnson $1,058,429
Fiscal 2023
Executive Total
Paul Edick $2,136,766
Paul R. Edick $2,136,766
John Shannon $1,848,153
John P. Shannon $1,848,153
Steven M. Pieper $1,611,142
Beth P. Hecht $1,129,443
Ken Johnson $720,967
Fiscal 2022
Executive Total
Paul Edick $2,805,599
Paul R. Edick $2,805,599
John Shannon $1,530,218
John P. Shannon $1,530,218
Beth Hecht $1,270,561
Beth P. Hecht $1,270,561
Fiscal 2021
Executive Total
Paul R. Edick $3,764,134
Paul Edick $3,764,134
Barry Deutsch $1,799,120
John Shannon $1,728,640
John P. Shannon $1,728,640
Beth P. Hecht $1,424,994
Beth Hecht $1,424,994
Fiscal 2020
Executive Total
Paul Edick $2,264,349
John Shannon $1,436,428
Beth Hecht $1,244,394

Executive changes

Person Change Filed
Marla S. Persky Appointed 2026-06-30
John Shannon Appointed 2026-06-30
Nerissa Kreher Appointed 2026-06-30
James Brady Appointed 2025-03-28
Ricki Fairley Resigned 2025-03-28
Anh Nguyen Appointed 2025-02-24
Ken Johnson Retired 2025-02-24
Kevin McCulloch Appointed 2024-08-02
John P. Shannon Appointed 2024-07-08
John P. Shannon Appointed 2024-07-08
Marla S. Persky Appointed 2024-07-08
John Shannon Appointed 2024-07-08
Paul R. Edick Resigned 2024-07-08
John Shannon Appointed 2024-07-08
Paul R. Edick Resigned 2024-07-08
Marla S. Persky Appointed 2024-06-05
Ricki Fairley Appointed 2024-06-05
Paul R. Edick Appointed 2024-06-05
Ricki Fairley Appointed 2023-03-29

Leadership

Key facts CIK 1867096 CUSIP 98422E103 13F (30d) 19 filings 19 filers Visit website Investor relations